✦ LIBER ✦

Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma

✍ Scribed by Bruce D. Cheson; Jonathan W. Friedberg; Brad S. Kahl; Richard H. Van der Jagt; Lothar Tremmel

Book ID: 119936281
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 130 KB
Volume: 10
Category: Article
ISSN: 2152-2650
DOI: 10.3816/clml.2010.n.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lenalidomide plus rituximab can produce

Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma

✍ Tuscano, Joseph M.; Dutia, Mrinal; Chee, Karen; Brunson, Ann; Reed-Pease, Christ 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Bendamustine pharmacokinetic profile and

Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma

✍ Joel S. Owen; Murad Melhem; Julie A. Passarell; Denise D’Andrea; Mona Darwish; B 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 436 KB

Bendamustine is effective therapy in pat

Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma : Results from a Multicenter Study

✍ Brad S. Kahl; Nancy L. Bartlett; John P. Leonard; Ling Chen; Kristen Ganjoo; Mic 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Bendamustine in Patients With Rituximab-

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

✍ Friedberg, J. W.; Cohen, P.; Chen, L.; Robinson, K. S.; Forero-Torres, A.; La Ca 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 118 KB

Lymphocyte recovery is impaired in patie

Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab

✍ García Muñoz, Ricardo; Izquierdo-Gil, Araceli; Muñoz, Aura; Roldan-Galiacho, Ver 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 417 KB

Bendamustine and Rituximab for Indolent

Bendamustine and Rituximab for Indolent B-Cell Non-Hodgkin Lymphoma in Patients With Compensated Hepatitis C Cirrhosis: A Case Series

✍ Parker, Stacey M.; Hyder, Mustafa A.; Fesler, Mark J. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 92 KB